Onxeo announces its financial calendar for 2015
Onxeo S.A. (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces its financial calendar for 2015:
March 4, 2015 Full-year 2014 results
April 15, 2015 General shareholders’ meeting (to be convened in Paris)
April 15, 2015 Quarterly information as of March 31, 2015
July 30, 2015 Consolidated accounts for the 1st half of 2015
November 5, 2015 Quarterly information as of September 30, 2015
This financial calendar is for indicative purposes only and Onxeo could change its publication dates should it deem it necessary.